Cerus (CERS) Income from Continuing Operations (2010 - 2026)
Cerus' (CERS) quarterly Income from Continuing Operations came in at -$3.0 million in Q2 2026, up 47.82% year-over-year from -$2.0 million in Q2 2025, and down 80.95% quarter-over-quarter from -$1.6 million in Q1 2026.
Powered by 
Analysis
Cerus (CERS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Cerus has disclosed Income from Continuing Operations across 15 years of filings, most recently posting -$3.0 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 47.82% year-over-year to -$3.0 million; the TTM figure through Jun 2026 stood at -$18.1 million (up 40.48% YoY), while the FY2021 annual figure was -$43.4 million, up 10.94% from the prior year.
- Income from Continuing Operations came in at -$3.0 million for Q2 2026 at Cerus, down from -$1.6 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of -$1.6 million in Q1 2026 to a low of -$12.3 million in Q1 2022.
- Average Income from Continuing Operations over 3 years is -$6.8 million, with a median of -$7.7 million recorded in 2025.
- Year-over-year, Income from Continuing Operations rose 29.63% in 2022 and soared 78.65% in 2026.
- Over 3 years, Income from Continuing Operations stood at -$8.5 million in 2022, then jumped by 32.93% to -$5.7 million in 2025, then soared by 47.82% to -$3.0 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$3.0 million in Q2 2026, -$1.6 million in Q1 2026, and -$5.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn | -2.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.98 Mn |
| Mar 31, 2026 | -1.65 Mn |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Sep 30, 2022 | -8.52 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | -12.28 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | -12.44 Mn |
| Jun 30, 2021 | -15.36 Mn |
| Mar 31, 2021 | -17.46 Mn |
| Dec 31, 2020 | -3.26 Mn |
| Sep 30, 2020 | -14.14 Mn |
| Jun 30, 2020 | -14.87 Mn |
| Mar 31, 2020 | -16.47 Mn |
| Dec 31, 2019 | -2.72 Mn |
| Sep 30, 2019 | -17.97 Mn |
| Jun 30, 2019 | -17.56 Mn |
| Mar 31, 2019 | -18.79 Mn |
| Dec 31, 2018 | -4.65 Mn |